Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Clinical trial NCT03817502 · RECRUITING
Trial details
- NCT number
- NCT03817502
- Sponsor
- Gedeon Richter Plc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2026-12-15
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.